[1]
Eder, P. et al. 2015. Safety profile of anti-tumor necrosis factor therapy in inflammatory bowel disease – a single center experience. Journal of Medical Science. 84, 3 (Sep. 2015), 146–151. DOI:https://doi.org/10.20883/medical.e11.